|
|
Other links at Articles > Pharmacists |
| 1. |
Heparin Agent M118 Matches Heparin in PCI Trial
|
|
|
A new low molecular weight heparin that supposedly combines the benefits of unfractionated heparin and enoxaparin is safe and feasible during percutaneous coronary intervention (PCI), phase 2 trial data show. Reuters Health Information
|
| 4. |
Vascular Dementia
|
|
|
Therapy for cognitive impairment caused by cerebrovascular disease is challenging -- the key may be in its prevention. U.S. Pharmacist
|
|
|